News and Events

Guided Therapeutics, Inc. New Stock Ticker Symbol - GTHP ... Read More

Guided Therapeutics, Inc. and Konica Minolta Look to Expand Cancer Detection Technology ... Read More

Agreement Signed to Manufacture New Non-invasive Cancer Detection Devices  ...Read More

New Painless Test for Cervical Cancer Could Provide Access to Better Healthcare for Women Worldwide ...Read More

Pre-PMA Meetings Held with FDA on Painless Cervical Cancer Test ... Read More

Painless Cancer Test May Eliminate Half of Unnecessary Cervical Biopsies ... Read More

National Cancer Institute Awards Fifth Grant  for Non-invasive Cervical Cancer Detection Technology ... Read More

Two Clinical Studies Indicate Non-invasive Cervical Cancer Detection Device Accurately Detects Disease While Reducing False Positive Results ... Read More

Patent Granted for Non-invasive Cervical Cancer Detection Technology ... Read More

First Pre-production Non-invasive Cervical Cancer Detection Device Successfully Built and Tested ... Read More

Guided Therapeutics Begins Initial Phase of FDA Pivotal ... Read More

Published Study Shows 81% of Women Want Guided Therapeutics Test to Replace Pap ... Read More

New Science and Technology devoted to painlessly detecting cervical disease before it becomes cancer and helping to preserve reproductive health.

We are formally known as SpectRx, Inc. Our new stock symbol is GTHP.

We are updating our web site. Check back soon!

Dr. Lisa Flowers of Emory University, one of the Principal Investigators for Guided Therapeutics, discusses a clinical trial with a patient. (Photo courtesy of Emory University)